Effect of Chronic Exposure to Antipsychotic Medication on Cell Numbers in the Parietal Cortex of Macaque Monkeys

Both in vivo and post-mortem investigations have demonstrated smaller volumes of the whole brain and of certain brain regions in individuals with schizophrenia. It is unclear to what degree such smaller volumes are due to the illness or to the effects of antipsychotic medication treatment. Indeed, we recently reported that chronic exposure of macaque monkeys to haloperidol or olanzapine, at doses producing plasma levels in the therapeutic range in schizophrenia subjects, was associated with significantly smaller total brain weight and volume, including an 11.8–15.2% smaller gray matter volume in the left parietal lobe. Consequently, in this study we sought to determine whether these smaller volumes were associated with lower numbers of the gray matter's constituent cellular elements. The use of point counting and Cavalieri's principle on Nissl-stained sections confirmed a 14.6% smaller gray matter volume in the left parietal lobe from antipsychotic-exposed monkeys. Use of the optical fractionator method to estimate the number of each cell type in the gray matter revealed a significant 14.2% lower glial cell number with a concomitant 10.2% higher neuron density. The numbers of neurons and endothelial cells did not differ between groups. Together, the findings of smaller gray matter volume, lower glial cell number, and higher neuron density without a difference in total neuron number in antipsychotic-exposed monkeys parallel the results of post-mortem schizophrenia studies, and raise the possibility that such observations in schizophrenia subjects might be due, at least in part, to antipsychotic medication effects.

[1]  W. Scherle,et al.  A simple method for volumetry of organs in quantitative stereology. , 1970, Mikroskopie.

[2]  H. Gundersen,et al.  Notes on the estimation of the numerical density of arbitrary profiles: the edge effect , 1977 .

[3]  J. Hinds,et al.  Gliogenesis of astrocytes and oligodendrocytes in the neocortical grey and white matter of the adult rat: Electron microscopic analysis of light radioautographs , 1980, The Journal of comparative neurology.

[4]  R. Østerby,et al.  Optimizing sampling efficiency of stereological studies in biology: or ‘Do more less well!‘ , 1981, Journal of microscopy.

[5]  F. Benes,et al.  Synaptic rearrangements in medial prefrontal cortex of haloperidol-treated rats , 1985, Brain Research.

[6]  H. Gundersen Stereology of arbitrary particles * , 1986, Journal of microscopy.

[7]  Stereology of Arbitrarily Shaped Particles: Unbiased Estimation of Number and Sizes , 1986 .

[8]  H J Gundersen,et al.  The efficiency of systematic sampling in stereology and its prediction * , 1987, Journal of microscopy.

[9]  C. LeBlond,et al.  Radioautographic evidence for slow astrocyte turnover and modest oligodendrocyte production in the corpus callosum of adult mice infused with 3H‐thymidine , 1988, The Journal of comparative neurology.

[10]  P. Rakic,et al.  Glial cell lineage in the cerebral cortex: A review and synthesis , 1991, Glia.

[11]  H. Gundersen,et al.  Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.

[12]  V. Perry,et al.  Turnover of resident microglia in the normal adult mouse brain , 1992, Neuroscience.

[13]  W. Richardson,et al.  Cell death and control of cell survival in the oligodendrocyte lineage , 1992, Cell.

[14]  B. Pakkenberg,et al.  Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors , 1993, Biological Psychiatry.

[15]  M. Raff,et al.  Evidence for large-scale astrocyte death in the developing cerebellum , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  F. Holsboer,et al.  Haloperidol-induced cell death—mechanism and protection with vitamin E in vitro , 1995, Neuroreport.

[17]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[18]  É. Mezey,et al.  Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Kapur,et al.  The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study , 1997, Psychopharmacology.

[20]  T. Gillespie,et al.  Disposition and biotransformation of the antipsychotic agent olanzapine in humans. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[21]  T. Gillespie,et al.  Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[22]  V. Howard,et al.  Unbiased Stereology: Three-Dimensional Measurement in Microscopy , 1998 .

[23]  Alan A. Wilson,et al.  5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. , 1998, The American journal of psychiatry.

[24]  J. Sweeney,et al.  Decreased caudate volume in neuroleptic-naive psychotic patients. , 1998, The American journal of psychiatry.

[25]  Tyrone D. Cannon,et al.  A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. , 1998, Archives of general psychiatry.

[26]  K. Jellinger,et al.  The neuropathology of schizophrenia. , 1999, Journal of neuropathology and experimental neurology.

[27]  Konrad Sandau,et al.  Unbiased Stereology. Three‐Dimensional Measurement in Microscopy. , 1999 .

[28]  A. Sampson,et al.  Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. , 1999, The American journal of psychiatry.

[29]  Paul J. Harrison The neuropathology of schizophrenia , 2008 .

[30]  J. Pierri,et al.  Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. , 1999, The American journal of psychiatry.

[31]  P. Rezaie,et al.  Colonisation of the developing human brain and spinal cord by microglia: a review , 1999, Microscopy research and technique.

[32]  P. Goldman-Rakic,et al.  Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure , 1999, Biological Psychiatry.

[33]  H. Gundersen,et al.  The efficiency of systematic sampling in stereology — reconsidered , 1999, Journal of microscopy.

[34]  P. Shinnick‐Gallagher,et al.  Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia , 2001, Neuroscience.

[35]  R. McCarley,et al.  A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.

[36]  J. Lieberman,et al.  Longitudinal study of brain morphology in first episode schizophrenia , 2001, Biological Psychiatry.

[37]  J. Pierri,et al.  Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. , 2001, The American journal of psychiatry.

[38]  Patricia Desmond,et al.  A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia , 2001, Schizophrenia Research.

[39]  B. Pakkenberg,et al.  No deficit in total number of neurons in the prefrontal cortex in schizophrenics. , 2001, Journal of psychiatric research.

[40]  J R Nyengaard,et al.  Tissue shrinkage and unbiased stereological estimation of particle number and size * , 2001, Journal of microscopy.

[41]  B. Lund,et al.  Olanzapine Plasma Concentrations and Clinical Response: Acute Phase Results of the North American Olanzapine Trial , 2001, Journal of clinical psychopharmacology.

[42]  P. Goldman-Rakic,et al.  Smaller frontal gray matter volume in postmortem schizophrenic brains. , 2002, The American journal of psychiatry.

[43]  D. Mousseau,et al.  Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide , 2003, Journal of neuroscience research.

[44]  Stephen R. Peters The Art of Embedding Tissue for Frozen Section. Part I: A System for Precision Face Down Cryoembedding of Tissues Using Freezing Temperature-Embedding Wells , 2003 .

[45]  Patrick R Hof,et al.  Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia , 2003, Biological Psychiatry.

[46]  The Art of Embedding Tissue for Frozen Section. Part II: Frozen Block Cryoembedding , 2003 .

[47]  C. Beasley,et al.  Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density , 2003, Biological Psychiatry.

[48]  Ethan M. Goldberg,et al.  Smaller anterior hippocampal formation volume in antipsychotic-naive patients with first-episode schizophrenia. , 2003, The American journal of psychiatry.

[49]  Jens R. Nyengaard,et al.  Estimation of number and volume of immunohistochemically stained neurons in complex brain regions , 2004 .

[50]  Honghong Zhang,et al.  Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus , 2004, Brain Research.

[51]  Bente Pakkenberg,et al.  Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. , 2004, The American journal of psychiatry.

[52]  R. Emsley,et al.  A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis. , 2004, The international journal of neuropsychopharmacology.

[53]  M. Tateno,et al.  Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol , 2004, Journal of Neural Transmission.

[54]  R. Duman,et al.  Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat , 2004, Biological Psychiatry.

[55]  Stephen M. Evans,et al.  Quantitative Methods in Neuroscience , 2004 .

[56]  A. Sampson,et al.  Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: Volume, neuron number, and cell types , 2004, The Journal of comparative neurology.

[57]  D. Dwyer,et al.  Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38 , 2004, Brain Research.

[58]  D. Lewis,et al.  Mapping auditory core, lateral belt, and parabelt cortices in the human superior temporal gyrus , 2005, The Journal of comparative neurology.

[59]  J. Lieberman,et al.  Antipsychotic drug effects on brain morphology in first-episode psychosis. , 2005, Archives of general psychiatry.

[60]  D. van der Kooy,et al.  Dopamine Specifically Inhibits Forebrain Neural Stem Cell Proliferation, Suggesting a Novel Effect of Antipsychotic Drugs , 2005, The Journal of Neuroscience.

[61]  John Suckling,et al.  Different Effects of Typical and Atypical Antipsychotics on Grey Matter in First Episode Psychosis: the ÆSOP Study , 2005, Neuropsychopharmacology.

[62]  Zhuoxin Sun,et al.  The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys , 2005, Neuropsychopharmacology.

[63]  F. Fumagalli,et al.  Long-Term Exposure to the Atypical Antipsychotic Olanzapine Differently Up-Regulates Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylation in Subcellular Compartments of Rat Prefrontal Cortex , 2006, Molecular Pharmacology.